About: Experience with extracoporeal elimination therapy in myasthenia gravis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Experience with extracoporeal elimination therapy in myasthenia gravis Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	We describe our experience with plasma exchange (PE) and immunoadsorption in patients with myasthenia gravis. The group of 27 patients consists of 21 patients treated with PE and 6 patients who received immunoadsorption. PE therapy led to stabilization in 20 patients. In patients treated with immunoadsorption, therapy could be discontinued in 2 patients after 13 months of therapy, and the other 4 patients were stabilized without myasthenic crises after 6-9 years of therapy. Extracorporeal elimination therapy through PE or immunoadsorption is effective and sometimes life saving and is safe in the hands of an experienced team (6% complication rate). (C) 2011 Elsevier Ltd. All rights reserved. We describe our experience with plasma exchange (PE) and immunoadsorption in patients with myasthenia gravis. The group of 27 patients consists of 21 patients treated with PE and 6 patients who received immunoadsorption. PE therapy led to stabilization in 20 patients. In patients treated with immunoadsorption, therapy could be discontinued in 2 patients after 13 months of therapy, and the other 4 patients were stabilized without myasthenic crises after 6-9 years of therapy. Extracorporeal elimination therapy through PE or immunoadsorption is effective and sometimes life saving and is safe in the hands of an experienced team (6% complication rate). (C) 2011 Elsevier Ltd. All rights reserved. (en)
Title	Experience with extracoporeal elimination therapy in myasthenia gravis Experience with extracoporeal elimination therapy in myasthenia gravis (en)
skos:prefLabel	Experience with extracoporeal elimination therapy in myasthenia gravis Experience with extracoporeal elimination therapy in myasthenia gravis (en)
skos:notation	RIV/60162694:G44__/11:43874731!RIV13-MO0-G44_____
http://linked.open...avai/riv/aktivita	I S V Z
http://linked.open...avai/riv/aktivity	I, S, V, Z(MSM0021620820), Z(MZ0FNHK2005)
http://linked.open...iv/cisloPeriodika	3
http://linked.open...vai/riv/dodaniDat	2013
http://linked.open...aciTvurceVysledku	Brndiar, Miroslav
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Ministerstvo obrany / Univerzita obrany - Fakulta vojenského zdravotnictví Hradec Králové
http://linked.open...dnocenehoVysledku	198694
http://linked.open...ai/riv/idVysledku	RIV/60162694:G44__/11:43874731
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	Extracorporeal elimination; Myasthenic crisis; Immunotherapy; Plasmapheresis; Myasthenia gravis (en)
http://linked.open.../riv/klicoveSlovo	Extracorporeal elimination Immunotherapy Myasthenic crisis Plasmapheresis Myasthenia gravis
http://linked.open...odStatuVydavatele	GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV	[19F8F3694485]
http://linked.open...i/riv/nazevZdroje	Transfusion and Apheresis Science
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	8 (xsd:int)
http://linked.open...UplatneniVysledku	2011
http://linked.open...v/svazekPeriodika	45
http://linked.open...iv/tvurceVysledku	Bláha, Milan Filip, Stanislav Malý, Jaroslav Bláha, V. Brndiar, Miroslav Langrová, H. Lánská, Miriam Piťha, J.
http://linked.open...ain/vavai/riv/wos	000299141100006
http://linked.open...n/vavai/riv/zamer	The use of experimental and clinical models of metabolic processes, nutrition and pharmacotherapy for the advancement of knowledge, clinical practice and quality of life improvement Nové diagnostické indikátory a léčebné postupy v závislosti na různých obdobích života s důrazem na stáří
issn	1473-0502
number of pages	6 (xsd:int)
http://bibframe.org/vocab/doi	10.1016/j.transci.2011.10.003
http://localhost/t...ganizacniJednotka	G44

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 46 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software